Vol 55, No 1 (2021)
Response to Letter to the Editors
Published online: 2020-10-07

open access

Page views 703
Article views/downloads 594
Get Citation

Connect on Social Media

Connect on Social Media

A comment on the paper ‘Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors’ by Sapko et al.

Klaudia Sapko1, Anna Jamroz-Wiśniewska1, Michał Marciniec1, Marcin Kulczyński1, Anna Szczepańska-Szerej1, Konrad Rejdak1
Pubmed: 33026645
Neurol Neurochir Pol 2021;55(1):117.


Not available

Article available in PDF format

View PDF Download PDF file


  1. Lewczuk P, Kornhuber J, Mroczko BA, et al. comment to the paper "Biomarkers in Multiple Sclerosis" by Sapko. Neurol Neurochir Pol. ; 2020: 55.
  2. Sapko K, Jamroz-Wiśniewska A, Marciniec M, et al. Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors. Neurol Neurochir Pol. 2020; 54(3): 252–258.
  3. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006; 180(1-2): 17–28.
  4. Gastaldi M, Zardini E, Leante R, et al. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci. 2017; 38(Suppl 2): 217–224.
  5. Pryce G, Baker D. Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter? Mult Scler Relat Disord. 2018; 25: 131–137.
  6. Lo Sasso B, Agnello L, Bivona G, et al. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update. Medicina (Kaunas). 2019; 55(6).

Neurologia i Neurochirurgia Polska